StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
SRNE stock opened at $0.01 on Friday. The company has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.02. Sorrento Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.35.
Sorrento Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 7/22 – 7/26
- 3 Healthcare Dividend Stocks to Buy
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Financial Services Stocks Investing
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.